The existing portfolio of products includes segments like Immunosuppressant, Anti-biotics, Oncology & Anti-fungals. The wide range of products of Concord Biotech has attracted customers across the globe. Expertise in the field of development of novel formulations, the R&D team at Concord Biotech is working towards adding new products in the portfolio.
OVERVIEW
PRODUCT LIST
Products Offered
Products
Usage/Therapeutic Segment
Tacrolimus Monohydrate
Mycophenolate Mofetil
Mycophenolate Sodium
Cyclosporine
Sirolimus
Pimecrolimus
Immunosuppressant
Temsirolimus
Everolimus
Romidepsin
Mitomycin
Dactinomycin
Oncology
Vancomycin HCl
Teicoplanin
Fidaxomicin
Anti-Bacterial
Mupirocin
Mupirocin Calcium
Topical Antibiotic
Anidulafungin
Micafungin Sodium
Anti-Fungal
Milbemycin Oxime
Anthelmintic(Animal Health)
Lovastatin
Pravastatin Sodium
Hypolipemic
Penicillin-G Amidase Enzyme
Biocatalyst for 6-SPA,7-ADCA,
Cefixime,Cefdinir etc
APIs Under Development/Cosideration
Products
Usage/Therapeutic Segment
Daptomycin
Dalbavancin
Telavancin
Oritavancin
Retapamulin
Antibacterial
Doxorubicin
Epirubicin
Eribulin
Bleomycin
Ixabepilone/ Epothilone B
Ridaforolimus
Oncology
Others
Biologics/ Biosimilars
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and liability for patent infringement is exclusively understood at buyer’s risk.